• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 7133
Device Problems Contamination (1120); Tear, Rip or Hole in Device Packaging (2385)
Patient Problem No Patient Involvement (2645)
Event Date 09/15/2020
Event Type  malfunction  
Event Description
It was reported that device contamination occurred.The 70% stenosed, 5.0mmx 2.0mm, concentric, de novo target lesion was located in the non-tortuous and non-calcified right coronary artery.A 1.50mm x 15mm emerge balloon catheter was selected for use.However, a hole in the inner package was found and the sterility of the device got compromised.The procedure was completed with another of the same device.There were no patient complications reported and the patient's status was stable.
 
Manufacturer Narrative
Device evaluated by mfr.: returned product consisted of an emerge balloon catheter in the packaging hoop, in the pouch.The pouch was open.Analysis of the pouch, tip, balloon, inner/outer shaft, and hypotube included microscopic and visual inspection.Inspection revealed an open pouch.Closer inspection of the edges/seal area of the pouch material found that the pouch material showed a continuous seal, without any open channels, rips, or tears.Inspection of the rest of the device found no other damage or defect.
 
Event Description
It was reported that device contamination occurred.The 70% stenosed, 5.0mmx 2.0mm, concentric, de novo target lesion was located in the non-tortuous and non-calcified right coronary artery.A 1.50mm x 15mm emerge balloon catheter was selected for use.However, a hole in the inner package was found and the sterility of the device got compromised.The procedure was completed with another of the same device.There were no patient complications reported and the patient's status was stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EMERGE
Type of Device
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key10631113
MDR Text Key210385699
Report Number2134265-2020-13244
Device Sequence Number1
Product Code LOX
UDI-Device Identifier08714729806189
UDI-Public08714729806189
Combination Product (y/n)N
PMA/PMN Number
K121196
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 11/25/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/05/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/05/2022
Device Model Number7133
Device Catalogue Number7133
Device Lot Number0024074507
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/14/2020
Date Manufacturer Received11/09/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age48 YR
Patient Weight52
-
-